CYP2C9 allelic variants:: ethnic distribution and functional significance

被引：280

作者：

Xie, HG

Prasad, HC

Kim, RB

Stein, CM

机构：

[1] Vanderbilt Univ, Sch Med, Med Ctr, Div Clin Pharmacol,Dept Med, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2002年 / 54卷 / 10期

关键词：

CYP2C9; polymorphism; genotyping; allelic variants; ethnic variability; meta-analysis; pharmacogenetics;

D O I：

10.1016/S0169-409X(02)00076-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cytochrome P-450 (CYP) 2C9 CYP2C9 is a polymorphically expressed enzyme responsible for the metabolism of several clinically important drugs, some with a low therapeutic index. This review summarizes the structure-function relationship of the CYP2C9 promoter and coding regions, known polymorphisms, the functional significance of various CYP2C9 alleles in vitro and in vivo, and their population frequencies. In addition, possible molecular mechanisms underlying ethnic variability in the metabolism of CYP2C9 substrate drugs are discussed. (C) 2002 Elsevier Science B.V. All rights reserved.

引用

页码：1257 / 1270

页数：14

共 83 条

[51]

Schwarz UI, 2001, CLIN PHARMACOL THER, V69, pP69

[52]

Scordo M. G., 2001, British Journal of Clinical Pharmacology, V51, p375P

[53] Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population [J].

Scordo, MG ;

Aklillu, E ;

Yasar, U ;

Dahl, ML ;

Spina, E ;

Ingelman-Sundberg, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :447-450

[54]

SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414

[55] Genetic polymorphisms and functional characterization of the 5′-flanking region of the human CYP2C9 gene:: In vitro and in vivo studies [J].

Shintani, M ;

Ieiri, I ;

Inoue, K ;

Mamiya, K ;

Ninomiya, H ;

Tashiro, N ;

Higuchi, S ;

Otsubo, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :175-182

[56] Individual sulfonylureas and serious hypoglycemia in older people [J].

Shorr, RI ;

Ray, WA ;

Daugherty, JR ;

Griffin, MR .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (07) :751-755

[57] Genetic association between sensitivity to warfarin and expression of CYP2C9*3 [J].

Steward, DJ ;

Haining, RL ;

Henne, KR ;

Davis, G ;

Rushmore, TH ;

Trager, WF ;

Rettie, AE .

PHARMACOGENETICS, 1997, 7 (05) :361-367

[58] Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes [J].

Streetman, DS ;

Bertino, JS ;

Nafziger, AN .

PHARMACOGENETICS, 2000, 10 (03) :187-216

[59]

STROM AR, 2000, DRUG METAB REV, V32, pP299

[60] Genetic analysis of the human cytochrome P450 CYP2C9 locus [J].

Stubbins, MJ ;

Harries, LW ;

Smith, G ;

Tarbit, MH ;

Wolf, CR .

PHARMACOGENETICS, 1996, 6 (05) :429-439

← 1 2 3 4 5 6 7 8 9 →